Testing effectiveness (Phase 2)Study completedNCT01521494
What this trial is testing
PA21 Phase II Clinical Study in Hemodialysis Patients With Hyperphosphatemia
Who this might be right for
Chronic Kidney Disease Requiring Hemodialysis
Kissei Pharmaceutical Co., Ltd. 183